Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaboxadol 12-month safety study in elderly outpatients with primary insomnia
2004-001264-45Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of gaboxadol in Insomnia, sponsored by Lundbeck. Primary endpoint: General safety and tolerability. Started Jul 2005; status: completed.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2004-001264-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001264-45.